Bavarian Nordic’s mpox vaccine to be trialled in pregnant women and infants
Bavarian Nordic’s mpox vaccine, Jynneos (MVA-BN), is set to be trialled in pregnant and breastfeeding women and infants. The Phase…
Bavarian Nordic’s mpox vaccine, Jynneos (MVA-BN), is set to be trialled in pregnant and breastfeeding women and infants. The Phase…
Donald Trump has been elected 47th president of the US after the 5 November election having won more than the…
Shares in Viking Therapeutics jumped after the company shared positive data from an early-stage trial of its obesity pill but…
Endevica Bio has launched a new spin-off company, Abisati, to accelerate its obesity candidate into clinical trials. The candidate, 710GO,…
A modified dosing regimen with Eli Lilly’s Alzheimer’s drug Kisunla (donanemab) has shown a reduction in amyloid-related imaging abnormalities with…
Johnson & Johnson (J&J) and Eli Lilly have both revealed the efficacy of their interleukin-23 (IL-23) inhibitors to treat Crohn’s…
With less than three weeks before Americans head to the polls, the election race is heating up. It is still…
The BIOSECURE Act’s impact is likely to benefit US-based manufacturing facilities as companies try to avoid falling foul of potential…
Cassava Sciences is moving forward with Phase III trials after paying $40m to settle an SEC case alleging misleading data…
Scholar Rock’s stock has soared off the back of positive Phase III results from its spinal muscular atrophy (SMA) candidate.…